coIMMUNE Revenue
Research Services • 
Durham, North Carolina, United States • 1-10 Employees
$
coIMMUNE revenue & valuation
| Annual revenue | $1,899,398 |
| Revenue per employee | $212,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Research Services industry and current estimated revenues | $6,100,000 |
| Total funding | No funding |
Key Contact at coIMMUNE
Charles Nicolette
Chief Executive Officer
Company overview
| Headquarters | 4233 Technology Dr, Durham, North Carolina 27704, US |
| Phone number | +19192876300 |
| Website | |
| Employees | 1-10 |
| Socials |
About coIMMUNE
coIMMUNE is a privately held, clinical stage immune-oncology company that will redefine cancer treatment using best-in-class cellular immunotherapies. Our allogeneic CAR-CIK technology platform for liquid and solid tumors is a novel CAR therapy that promises enhanced efficacy with greatly reduced toxicity.
Employees by Management Level
Total employees: 1-10
Seniority
Employees
C-Suite
Employees by Department
coIMMUNE has 2 employees across 2 departments.
Departments
Number of employees
Funding Data
coIMMUNE has never raised funding before.
Spain
Hong Kong
Germany
Frequently asked questions
coIMMUNE is located in Durham, North Carolina, US.
You can reach coIMMUNE at +19192876300.
coIMMUNE generates an estimated annual revenue of $1,899,398. This revenue figure reflects the company's market position and business performance in its industry.
coIMMUNE has an estimated valuation of $6,100,000. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.
coIMMUNE has approximately 1-10 employees. The company continues to grow its workforce to support its business operations and expansion.
4.8
40,000 users
